Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.
Fiche publication
Date publication
octobre 2016
Journal
BMC cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe, Pr BORG Christophe, Dr FEIN Francine, Pr HEYD Bruno, Dr VERNEREY Dewi, Dr KIM Stephano, Dr VUITTON Lucine, Dr LAKKIS Zaher
Tous les auteurs :
d'Engremont C, Vernerey D, Pointet AL, Simone G, Fein F, Heyd B, Koch S, Vuitton L, Kim S, Jary M, Lamfichek N, Turco C, Lakkis Z, Berger A, Bonnetain F, Taieb J, Bachellier P, Borg C
Lien Pubmed
Résumé
Pancreatic adenocarcinoma (PDAC) incidence is increasing worldwide. Several studies have shown that lymphopenia was correlated with a poor prognosis but the potential interest to measure lymphopenia in the pre and post-operative setting as well as its added value among conventional prognostic factors was never investigated.
Mots clés
Lymphocyte count, Lymphopenia, Pancreatic adenocarcinoma, Prognosis
Référence
BMC Cancer. 2016 Oct;16(1):823